U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07571928) titled 'A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia' on April 16.
Brief Summary: This clinical interventional study aims to assess whether treatment with with leflutrozole can improve sperm production in infertile men with non-obstructive azoospermia selected by serum anti-mullerian hormone (AMH) or Inhibin B as a positive predictive biomarker.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Infertility Due to Azoospermia
Infertility, Male
Intervention:
DRUG: Leflutrozole, Dose 2
Leflutrozole capsule 0.3 mg once weekly administered orally
Recruitment Status: NOT_YET_RECRUITING...